Aemetis Inc. buy krebskrebs
Start price
25.01.21
/
50%
€4.10
Target price
25.01.22
€4.50
Performance (%)
101.22%
End price
26.01.22
€8.25
Summary
This prediction ended on 26.01.22 with a price of €8.25. With a performance of 101.22% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aemetis Inc. | 1.587% | 1.587% | -46.667% | -66.876% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% | 64.224% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% | 107.611% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% | 57.276% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% | 67.009% |
Comments by krebskrebs for this prediction
In the thread Aemetis Inc. diskutieren
In the thread Trading Aemetis Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten